Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02954900 · ClinicalTrials.gov registry record · NA
Know Your Risk: Assessment at Screening for Breast Cancer - Pilot Study
A NA study of Breast Neoplasms, sponsored by Columbia University.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT02954900: Completed NA study of Breast Neoplasms, sponsored by Columbia University.
NCT02954900 is a NA study of Breast Neoplasms that has completed, run by Columbia University. The registered enrollment target is 40 participants, below the 569-participant average among 97 other Breast Neoplasms trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02954900, a NA study of Breast Neoplasms, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this pilot study is to evaluate a decision support website (RealRisks) designed to inform patients about breast cancer chemoprevention. It is coupled with a physician-centered (BNAV) decision support website as part of clinical workflow in the primary care setting. The investigator hypothesizes that improving accuracy of breast cancer risk perception and understanding of the risks/benefits of chemoprevention will enhance informed decision-making and uptake of breast cancer prevention strategies in the primary care setting.
Primary Outcome
To measure the patient's accuracy of perceived breast cancer risk before and after exposure to the RealRisks decision aid. Perception will be assessed by comparing the difference between a patient's perceived risk and their actual risk based on the Gail breast cancer model. Patients are asked to make a comparative risk assessment about themselves on a 3-point Likert scale.
Conditions Studied
Interventions
- OTHER RealRisks
- OTHER BNAV
Study Locations (1)
New York
- Columbia University Medical Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2016-03-15 |
| Est. Completion | 2018-10 |
| Phase | NA |
What the finished NCT02954900 record still lists
NCT02954900 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 569-participant average among 97 other Breast Neoplasms trials with a reported enrollment target (93% lower).
The record links to 1 condition, with Breast Neoplasms appearing as the primary indexed condition, and to 2 interventions - of which RealRisks is the first listed.
NCT02954900 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT02954900 about?
NCT02954900 is a clinical study titled "Know Your Risk: Assessment at Screening for Breast Cancer - Pilot Study". The purpose of this pilot study is to evaluate a decision support website (RealRisks) designed to inform patients about breast cancer chemoprevention. It is coupled with a physician-centered (BNAV) decision support website as part of clinical workflow in the primary care setting. The investigator hy...
What is the current status of trial NCT02954900?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2016-03-15. Estimated completion is 2018-10.
What conditions does trial NCT02954900 study?
This clinical trial studies the following conditions: Breast Neoplasms.
What interventions are being tested in trial NCT02954900?
The interventions under investigation include: RealRisks (OTHER), BNAV (OTHER).
Who is sponsoring clinical trial NCT02954900?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02954900 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Neoplasms
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02954900's enrollment target sits among peer trials
40 80th of 97 higher than 17 of 97 other Breast Neoplasms trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Breast Neoplasms trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Breast Cancer, Reasoning, and Activity Intervention
RECRUITING · NA
-
Biennial CEM in Women With a Personal History of Breast Cancer
RECRUITING · NA
-
Integrating Biological, Clinical, and Behavioral Factors to Improve Breast Cancer Outcomes - Carolina Breast Cancer Study
RECRUITING · NA
-
Dissemination of BREASTChoice AIM1-B
RECRUITING · NA
-
The IDEA Study (Individualized Decisions for Endocrine Therapy Alone)
ACTIVE NOT RECRUITING · NA
-
Lifestyle, Exercise, and Nutrition Study Early After Diagnosis
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI